AQST - Aquestive Therapeutics GAAP EPS of -$0.36 in-line revenue of $13.27M beats by $2.7M
- Aquestive Therapeutics press release ( NASDAQ: AQST ): Q2 GAAP EPS of -$0.36 in-line.
- Revenue of $13.27M (-13.5% Y/Y) beats by $2.7M .
- 2022 Guidance:
- Total revenue (in millions) - $46 to $49M from prior forecast $42 to $47M($46.46M consensus)
For further details see:
Aquestive Therapeutics GAAP EPS of -$0.36 in-line, revenue of $13.27M beats by $2.7M